Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01736943
Title Bortezomib and Doxil for the Treatment of Patients With Acute Myelogenous Leukemia
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, Davis
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of California Comprehensive Cancer Center Sacramento California 95817 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field